Hence, we hypothesized that the regulation of FASN levels by USP14 is a minor indirect effect and that the regulation of cancer proliferation by USP14 is through a pathway other than the FASN-controlled de novo lipogenesis pathway. This evidence concerns the gene USP14 and cancer.